Previous work has demonstrated that inflammation induces the kynurenine pathway of tryptophan metabolism by increasing the activity of indoleamine-2,3-dioxygensase. Previous studies in schizophrenia have shown alterations in these markers/metabolites, though have only considered a small number of each.